首页> 外文期刊>Clinical chemistry and laboratory medicine: CCLM >Bayesian analysis of an international ELISA comparability study.
【24h】

Bayesian analysis of an international ELISA comparability study.

机译:国际ELISA可比性研究的贝叶斯分析。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND: Immunoassays are biochemical tests applied to measure even very small amounts of substance using the highly specific binding between an antibody and its antigen. They have a wide range of applications. The measurement however, might be associated with substantial uncertainty; this can have significant consequences for any diagnosis, or clinical decision. An international comparability study was thus performed to assess the sources of uncertainty involved in the estimation of a protein cytokine concentration using a fluorescent ELISA. METHODS: In contrast to the original publication for this international comparability study, we reanalyse the data using Bayesian inference. This provides a statistically coherent approach to estimate ELISA concentrations and their associated uncertainties. RESULTS: The Bayesian uncertainties of individual ELISAs and laboratory estimates are considerably larger than previously reported uncertainties. The average concentrations estimated here differ from the ones estimated by each study participant. In general, this leads to different conclusions about the study. In particular, the inter- and intra-laboratory consistency is increased, and repeatability problems occur for fewer laboratories. CONCLUSIONS: Decisions which are based on plausible ranges of measurements (such as credible intervals), are generally superior to those solely based on point estimates (such as the mean). Reliable uncertainties are thus vital, and not only in metrology. In this paper, a general method is developed to derive concentration estimates and valid uncertainties for ELISAs. Guidance on applying this Bayesian method is provided and the importance of reliable uncertainties associated with ELISAs is underlined. The applicability and virtues of the presented method are demonstrated in the context of an international comparability study.
机译:背景:免疫分析是一种生化测试,用于利用抗体及其抗原之间的高度特异性结合来测量甚至很少量的物质。它们具有广泛的应用范围。但是,该测量可能会带来很大的不确定性。这可能会对任何诊断或临床决策产生重大影响。因此,进行了一项国际可比性研究,以评估使用荧光ELISA估算蛋白质细胞因子浓度所涉及的不确定性来源。方法:与该国际可比性研究的原始出版物不同,我们使用贝叶斯推断重新分析数据。这提供了一种统计上一致的方法来估算ELISA浓度及其相关的不确定性。结果:单个ELISA和实验室估计的贝叶斯不确定性比以前报道的不确定性大得多。这里估计的平均浓度不同于每个研究参与者估计的浓度。通常,这会导致有关研究的不同结论。特别是,实验室间和实验室内的一致性提高了,而实验室数量较少的情况下出现了重复性问题。结论:基于合理的测量范围(例如可信区间)的决策通常优于仅基于点估计(例如均值)的决策。因此,可靠的不确定性至关重要,不仅在计量方面。在本文中,开发了一种通用方法来得出ELISA的浓度估计值和有效不确定度。提供了使用该贝叶斯方法的指南,并强调了与ELISA相关的可靠不确定性的重要性。在国际可比性研究的背景下证明了所提出方法的适用性和优点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号